lithium has been researched along with Brain Ischemia in 15 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (13.33) | 18.7374 |
| 1990's | 3 (20.00) | 18.2507 |
| 2000's | 3 (20.00) | 29.6817 |
| 2010's | 3 (20.00) | 24.3611 |
| 2020's | 4 (26.67) | 2.80 |
| Authors | Studies |
|---|---|
| Ates, N; Balcikanli, Z; Beker, MC; Caglayan, A; Caglayan, AB; Caglayan, B; Celik, S; Dasdelen, MF; Dilsiz, P; Doeppner, TR; Hermann, DM; Kilic, E; Ozbek, H; Sertel, E; Yigitbasi, T | 1 |
| Chao, LC; Huang, CC; Huang, SY; Lee, AH; Lee, EJ; Lin, YW; Shan, YS; Tai, SH; Wu, TS | 1 |
| An, J; Boehm-Sturm, P; Bugaeva, P; Endres, M; Fekonja, LS; Harms, C; Hoffmann, CJ; Koch, SP; Koschützke, L; Kuffner, MT; Lips, J; Lorenz, S; Mueller, S; Rex, A; Tünnemann, GL | 1 |
| Kumar, R; Rana, AK; Shukla, DN; Singh, D | 1 |
| Chen, WJ; Huang, CC; Hung, HC; Lin, CL; Liu, GY; Tung, JN; Tung, WF | 1 |
| Ramagiri, S; Taliyan, R | 1 |
| Khasanov, NR; Khasanova, DR; Oslopov, VN; Safiullina, AA; Zhitkova, IuV | 1 |
| Ma, J; Zhang, GY | 1 |
| Hao, ZB; Liu, Y; Ma, J; Yan, JZ; Zhang, GY | 1 |
| Gu, ZL; Han, R; Hua, YN; Miao, YZ; Qin, ZH; Wu, JC; Xu, XH; Zhang, HL | 1 |
| Bobkov, IuG; Ivanova, IA | 1 |
| Bacic, G; Du, H; Dunn, JF; Hoopes, PJ; Jiang, J; Liu, KJ; Ou, LC; Swartz, HM | 1 |
| Lin, TA; Sun, GY; Zhang, JP | 1 |
| Bacic, G; Dunn, JF; Hoopes, PJ; Liu, KJ; Rolett, EL; Swartz, HM | 1 |
| Bobkov, IuG; Ivanova, IA; Losev, AS | 1 |
15 other study(ies) available for lithium and Brain Ischemia
| Article | Year |
|---|---|
Phosphorylation of PI3K/Akt at Thr308, but not phosphorylation of MAPK kinase, mediates lithium-induced neuroprotection against cerebral ischemia in mice.
Topics: Animals; Apoptosis; Brain Ischemia; Cerebral Infarction; Glycogen Synthase Kinase 3 beta; Lithium; Mice; Mitogen-Activated Protein Kinase Kinases; Neuroprotection; Neuroprotective Agents; Phosphatidylinositol 3-Kinases; Phosphorylation; Proto-Oncogene Proteins c-akt; Stroke | 2022 |
Lithium upregulates growth-associated protein-43 (GAP-43) and postsynaptic density-95 (PSD-95) in cultured neurons exposed to oxygen-glucose deprivation and improves electrophysiological outcomes in rats subjected to transient focal cerebral ischemia foll
Topics: Animals; Brain Ischemia; Brain-Derived Neurotrophic Factor; Disks Large Homolog 4 Protein; Edetic Acid; GAP-43 Protein; Glucose; Glycogen Synthase Kinase 3 beta; Infarction, Middle Cerebral Artery; Lithium; Lithium Chloride; Male; N-Methylaspartate; Neurons; Neuroprotective Agents; Oxygen; Rats; Rats, Sprague-Dawley; Receptors, N-Methyl-D-Aspartate; Sodium Dodecyl Sulfate | 2022 |
Zfp580 inactivation as a new therapeutic target to enhance recovery after stroke in mice.
Topics: Animals; Brain Ischemia; Interleukin-6; Lithium; Mice; Signal Transduction; Stroke; Transcription Factors | 2023 |
Lithium co-administration with rutin improves post-stroke neurological outcomes via suppressing Gsk-3β activity in a rat model.
Topics: Animals; Brain Ischemia; Glycogen Synthase Kinase 3 beta; Lithium; Male; Neuroprotective Agents; Nitric Oxide; Rats; Reperfusion Injury; Rutin; Stroke | 2023 |
4-Phenylbutyric Acid (4-PBA) and Lithium Cooperatively Attenuate Cell Death during Oxygen-Glucose Deprivation (OGD) and Reoxygenation.
Topics: Brain Ischemia; Cell Death; Cells, Cultured; Drug Synergism; Endoplasmic Reticulum Stress; Glucose; Humans; Hypoxia; Lithium; Neurons; Neuroprotective Agents; Oxygen; Oxygen Consumption; Phenylbutyrates; Reperfusion Injury | 2015 |
Delayed neuroprotection against cerebral ischemia reperfusion injury: putative role of BDNF and GSK-3β.
Topics: Animals; Brain Ischemia; Brain-Derived Neurotrophic Factor; Gene Expression Regulation; Glycogen Synthase Kinase 3 beta; Humans; Infarction, Middle Cerebral Artery; Lithium; Male; Neuroprotective Agents; Oxidative Stress; Rats; Reperfusion Injury; Tumor Necrosis Factor-alpha | 2016 |
[Efficacy of adepress (paroxetine) in the treatment of depression in patients with chronic cerebral ischemia in the late recovery phase of ischemic stroke with the estimation of the velocity of passive transmembrane ion transport].
Topics: Aged; Antidepressive Agents, Second-Generation; Brain Ischemia; Chronic Disease; Cognition; Depression; Erythrocyte Membrane; Female; Humans; Ion Transport; Lithium; Male; Middle Aged; Paroxetine; Sodium; Treatment Outcome | 2012 |
Lithium reduced N-methyl-D-aspartate receptor subunit 2A tyrosine phosphorylation and its interactions with Src and Fyn mediated by PSD-95 in rat hippocampus following cerebral ischemia.
Topics: Animals; Brain Ischemia; Disks Large Homolog 4 Protein; Hippocampus; Intracellular Signaling Peptides and Proteins; Lithium; Male; Membrane Proteins; Nerve Tissue Proteins; Phosphorylation; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-fyn; Rats; Rats, Sprague-Dawley; Receptors, N-Methyl-D-Aspartate; src-Family Kinases; Tyrosine | 2003 |
Lithium suppressed Tyr-402 phosphorylation of proline-rich tyrosine kinase (Pyk2) and interactions of Pyk2 and PSD-95 with NR2A in rat hippocampus following cerebral ischemia.
Topics: Animals; Brain Ischemia; Disks Large Homolog 4 Protein; Focal Adhesion Kinase 2; Hippocampus; Immunoblotting; Intracellular Signaling Peptides and Proteins; Lithium; Male; Membrane Proteins; Nerve Tissue Proteins; Phosphorylation; Precipitin Tests; Proline; Protein-Tyrosine Kinases; Rats; Rats, Sprague-Dawley; Receptors, N-Methyl-D-Aspartate; src-Family Kinases; Time Factors; Tyrosine | 2004 |
Greater stress protein expression enhanced by combined prostaglandin A1 and lithium in a rat model of focal ischemia.
Topics: Animals; Apoptotic Protease-Activating Factor 1; Brain Ischemia; Disease Models, Animal; DNA-Binding Proteins; Heat Shock Transcription Factors; Heme Oxygenase (Decyclizing); HSP90 Heat-Shock Proteins; Lithium; Male; Prostaglandins A; Rats; Rats, Sprague-Dawley; Transcription Factors | 2007 |
[Comparative study of several preparations in different models of cerebral hypoxia].
Topics: Animals; Asphyxia; Brain Ischemia; Disease Models, Animal; Drug Evaluation, Preclinical; Electrocardiography; Electroencephalography; Guanylthiourea; Hydroxybutyrates; Hypoxia, Brain; Lithium; Male; Organometallic Compounds; Piracetam; Rats; Sodium Nitrite; Sodium Oxybate | 1984 |
Assessment of cerebral pO2 by EPR oximetry in rodents: effects of anesthesia, ischemia, and breathing gas.
Topics: Anesthetics; Animals; Brain Chemistry; Brain Ischemia; Electron Spin Resonance Spectroscopy; Evaluation Studies as Topic; Indoles; Lithium; Magnetic Resonance Imaging; Male; Molecular Probes; Organometallic Compounds; Oximetry; Oxygen; Partial Pressure; Rats; Rats, Wistar; Respiration | 1995 |
Metabolism of inositol 1,4,5-trisphosphate in mouse brain due to decapitation ischemic insult: effects of acute lithium administration and temporal relationship to diacylglycerols, free fatty acids and energy metabolites.
Topics: Animals; Brain; Brain Ischemia; Chromatography, High Pressure Liquid; Decerebrate State; Diglycerides; Energy Metabolism; Fatty Acids, Nonesterified; Inositol 1,4,5-Trisphosphate; Lithium; Male; Mice; Mice, Inbred C57BL; Phosphates; Time Factors | 1993 |
Histological assessment of rodent CNS tissues to EPR oximetry probe material.
Topics: Animals; Brain; Brain Ischemia; Carbon; Central Nervous System; Cerebrovascular Circulation; Electron Spin Resonance Spectroscopy; Gerbillinae; Indoles; Lithium; Magnetic Resonance Imaging; Male; Molecular Probes; Organometallic Compounds; Oximetry; Rats; Spin Labels; Spinal Cord | 1997 |
[Study of the mechanism of the anti-hypoxic action of lithium oxybutyrate using cerebral ischemia as a model].
Topics: Animals; Brain; Brain Ischemia; Energy Metabolism; Hydroxybutyrates; Lithium; Male; Malondialdehyde; Mice; Organometallic Compounds; Sodium Oxybate | 1985 |